Dexamethasone to improve maternal outcome in women with hemolysis, elevated liver enzymes, and low platelets syndrome

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 5, 2005, Pages 1587-1590

  Sibai, Baha M ^a,c   Barton, John R ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CENTRAL BAPTIST HOSPITAL   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; MAGNESIUM SULFATE;

CLINICAL TRIAL; CONVULSION; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; DRUG EFFECT; EDITORIAL; FEMALE; HELLP SYNDROME; HUMAN; KIDNEY FAILURE; LIVER DISEASE; LUNG EDEMA; MATERNAL CARE; PRIORITY JOURNAL; PROPHYLAXIS; SIDE EFFECT; TRANSFUSION; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; FEMALE; HELLP SYNDROME; HUMANS; PREGNANCY; PREGNANCY OUTCOME;

EID: 27544503182     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.08.006     Document Type: Editorial

References (23)

1. B.M. Sibai Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count Obstet Gynecol 103 2004 981 991
2. J.A. Pritchard, R. Weisman, O.D. Ratoff, and G.F. Vosburg Intravascular hemolysis, thrombocytopenia, and other hematologic abnormalities associated with severe toxemia of pregnancy N Engl J Med 250 1954 89 98
3. A.P. Killiam, S.H. Dillard, R.C. Patton, and P.R. Pederson Pregnancy-induced hypertension complicated by acute liver disease and disseminated intravascular coagulation Am J Obstet Gynecol 123 1975 823 828
4. M. Lopez-Llera, M. Espinosa, M.D. DeLeon, and U.R. Linares Abnormal coagulation and fibrinolysis in eclampsia: a clinical and laboratory correlation study Am J Obstet Gynecol 124 1976 681 686
5. L. Weinstein Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy Am J Obstet Gynecol 142 1982 159 167
6. B.M. Sibai, M.M. Taslimi, A. El-Nazer, E. Amon, and C.B. Mabie Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia Am J Obstet Gynecol 155 1986 501 509
7. M.J. Tompkins, and S. Thiagarajah HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids Am J Obstet Gynecol 181 1999 304 309
8. W. Rath, W. Loos, W. Kuhn, and H. Graeff The importance of early laboratory screening methods for maternal and fetal outcome in cases of HELLP syndrome Eur J Obstet Gynecol Reprod Biol 36 1990 43 51
9. E.F. Magann, D. Bass, S.P. Chauhan, D.L. Sullivan, R.W. Martin, and J.N. Martin Jr. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) Am J Obstet Gynecol 171 1994 1148 1153
10. E.F. Magann, K.O. Perry Jr., E.F. Meydrech, R.L. Harris, S.P. Chauhan, and J.N. Martin Jr. Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) Am J Obstet Gynecol 171 1994 1154 1158
11. J.N. Martin Jr., B.D. Thigsen, C.H. Rose, J. Cushman, A. Moore, and W.L. May Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP Am J Obstet Gynecol 189 2003 830 834
12. C.H. Rose, B.D. Thigpen, J.A. Bofill, J. Cushman, W.L. May, and J.N. Martin Jr. Obstetric implications of antepartum corticosteroid therapy for HELLP syndrome Obstet Gynecol 104 2004 1011 1014
13. J.M. O'Brien, S.A. Shumate, S.L. Satchwell, D.A. Milligan, and J.R. Barton Maternal benefit of corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: impact on the rate of regional anesthesia Am J Obstet Gynecol 186 2002 475 479
14. P. Vigil-DeGracia, and E. Garcia-Caceres Dexamethasone in the postpartum treatment of HELLP syndrome Int J Gynaecol Obstet 59 1997 217 221
15. O.T. Yalcin, T. Sener, H. Hassa, S. Ozalp, and A. Okur Effects of postpartum corticosteroids in patients with HELLP syndrome Int J Gynaecol Obstet 61 1998 141 148
16. C.M. Isler, P.S. Barrilleaux, E.F. Magann, D. Bass, and J.N. Martin Jr. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP syndrome Am J Obstet Gynecol 184 2001 1332 1339
17. S. Thiagarajah, F.J. Bourgeois, G.M. Harbert, and M.R. Caudle Thrombocytopenia in preeclampsia: associated abnormalities and management principles Am J Obstet Gynecol 150 1984 1 7
18. P. Matchaba, and J. Moodley Corticosteroids for HELLP syndrome in pregnancy Cochrane Database Syst Rev 2004 CD002076
19. J.E. Fonseca, F. Mendez, C. Catano, and F. Arias Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double blind, placebo controlled, randomized clinical trial Am J Obstet Gynecol 193 2005 1591 1598
20. W. Visser, and H.C.S. Wallenburg Temporising management of severe preeclampsia with and without the HELLP syndrome Br J Obstet Gynaecol 101 1995 111 117
21. M.G. Van Pampus, H. Wolf, A. Ilsen, and P.E. Treffers Maternal outcome following temporizing management of HELLP syndrome Hypertens Pregnancy 19 2000 211 220
22. J.R. Barton, C.A. Riely, T.A. Adamec, D.R. Shanklin, A.D. Khoury, and B.M. Sibai Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) Am J Obstet Gynecol 167 1992 1538 1543
23. J.R. Barton, and B.M. Sibai Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) Am J Obstet Gynecol 174 1996 1820 1827